Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
121.61
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
40
Open
121.61
Bid (Size)
100.00 (1)
Ask (Size)
129.99 (1)
Prev. Close
121.61
Today's Range
121.61 - 121.61
52wk Range
76.61 - 173.25
Shares Outstanding
93,148,652
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
November 07, 2024
Via
Benzinga
This McKesson Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
November 07, 2024
Via
Benzinga
Performance
YTD
+26.40%
+26.40%
1 Month
-2.33%
-2.33%
3 Month
-5.47%
-5.47%
6 Month
-7.66%
-7.66%
1 Year
+52.64%
+52.64%
More News
Read More
Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript
November 07, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments
November 06, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 31, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Peeling Back The Layers: Exploring Sarepta Therapeutics Through Analyst Insights
October 21, 2024
Via
Benzinga
Unveiling 15 Analyst Insights On Sarepta Therapeutics
October 21, 2024
Via
Benzinga
Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results
October 23, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
October 21, 2024
Via
Benzinga
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
Via
Benzinga
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
October 18, 2024
Via
Investor's Business Daily
Analyst Scoreboard: 12 Ratings For Sarepta Therapeutics
October 04, 2024
Via
Benzinga
Unveiling 26 Analyst Insights On Sarepta Therapeutics
September 06, 2024
Via
Benzinga
2 High-Flying Growth Stocks With Massive Upside Potential
October 17, 2024
Via
The Motley Fool
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
October 03, 2024
Via
The Motley Fool
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
September 30, 2024
Via
MarketBeat
Exposures
Product Safety
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress
September 26, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors
September 16, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
These 2 Biotech Stocks Are Set to Soar
September 13, 2024
Via
The Motley Fool
Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year
September 05, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
September 03, 2024
Via
Benzinga
Dyne Called Its Sarepta-Rivaling Results 'Unprecedented,' But Its C-Suite Just Fled The Building
September 03, 2024
Via
Investor's Business Daily
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 30, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.